Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial. Lancet 2018 Mar 29. pii: S0140-6736(18)30291.
PMID: 29606364


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016